IDSA reached its goal, but nobody’s buying. Can the drowning antimicrobial pipeline be saved?
BY HELEN W. BOUCHER, MD, FACP, FIDSA
Advertisement
Articles by BY HELEN W. BOUCHER, MD, FACP, FIDSA
Advertisement
Latest Updated Articles
- Have we made progress in the 10 X' 20 Initative?
Published: April 9th 2020 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
New Data Highlight Adult Pneumococcal Serotypes with Greater Antibiotic Resistance and Disease Burden Covered by Merck’s Vaccine
2
Developing a COVID-19 Vaccine Alternative
3
Generic Lenacapavir Could Cost as Little as $25 Per Person Annually
4
Oral Carbapenem Tebipenem HBr Demonstrates Non-Inferiority to IV Therapy in Phase III PIVOT-PO Trial
5
